Page last updated: 2024-08-23

pefloxacin and E coli Infections

pefloxacin has been researched along with E coli Infections in 14 studies

Research

Studies (14)

Timeframe	Studies, this research(%)	All Research%
pre-1990	7 (50.00)	18.7374
1990's	5 (35.71)	18.2507
2000's	2 (14.29)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dunne, TS; Kuck, NA; Lin, YI; Moran, DB; Ziegler, CB	1
Kawakami, K; Kondo, H; Sakamoto, F; Tsukamoto, G	1
Cattoir, V; Nordmann, P; Poirel, L	1
El-Sukhon, SN; Faiza Boukhatem, Z	1
Carbon, C; Contrepois, A; Daldoss, C; Garaud, JJ; Kecir, M; Pangon, B; Sarrazin, C; Vallois, JM	1
Bernheim, J; Korzets, Z; Maayan, MC	1
Andremont, A; Carbon, C; Massias, L; Montravers, P	1
Benoît, G; Bensadoun, H; Blanchet, P; Blery, M; Costa, Y; el Helali, N; Jacques, L; Merrand, S; Rason, T; Yataghene, Y	1
Chan, MK; Chan, PC; Cheng, IK; Wong, WT	1
Bernard, E; Dellamonica, P; Durant, J; Elbaze, P	1
Bielefeld, P; Caillot, D; Guy, H; Kazmierczak, A; Portier, H; Solary, E	1
Auckenthaler, R; Marchou, B; Michéa-Hamzehpour, M; Pechère, JC	1
Hackbarth, CJ; Sande, MA; Shibl, AM	1
Carbone, M; Fera, MT; Mastroeni, P	1

Reviews

1 review(s) available for pefloxacin and E coli Infections

Article	Year
Flavobacterial peritonitis in patients treated by peritoneal dialysis. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1995, Volume: 10, Issue:2 Topics: Escherichia coli Infections; Flavobacterium; Gram-Negative Bacterial Infections; Humans; Kidney Failure, Chronic; Male; Middle Aged; Pefloxacin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Staphylococcal Infections; Trimethoprim, Sulfamethoxazole Drug Combination	1995

Article

Year

Flavobacterial peritonitis in patients treated by peritoneal dialysis.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1995, Volume: 10, Issue:2

Topics: Escherichia coli Infections; Flavobacterium; Gram-Negative Bacterial Infections; Humans; Kidney Failure, Chronic; Male; Middle Aged; Pefloxacin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Staphylococcal Infections; Trimethoprim, Sulfamethoxazole Drug Combination

1995

Trials

2 trial(s) available for pefloxacin and E coli Infections

Article	Year
Pefloxacin in the treatment of septicaemia: three years' experience. The Journal of antimicrobial chemotherapy, 1990, Volume: 26 Suppl B Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Drug Therapy, Combination; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Male; Middle Aged; Pefloxacin; Proteus Infections; Retrospective Studies; Sepsis; Time Factors	1990
[Combination of a 3d-generation cephalosporin (cefotaxime or ceftazidime) and a new quinolone (pefloxacine) in the treatment of febrile episodes in neutropenic diseases (37 cases)]. Presse medicale (Paris, France : 1983), 1987, Dec-16, Volume: 16, Issue:43 Topics: Agranulocytosis; Anti-Infective Agents; Cefotaxime; Ceftazidime; Drug Evaluation; Drug Therapy, Combination; Escherichia coli Infections; Feces; Fever; Focal Infection; Humans; Leukemia; Neutropenia; Norfloxacin; Pefloxacin; Pseudomonas Infections; Sepsis; Staphylococcal Infections	1987

Article

Year

Pefloxacin in the treatment of septicaemia: three years' experience.

The Journal of antimicrobial chemotherapy, 1990, Volume: 26 Suppl B

Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Drug Therapy, Combination; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Male; Middle Aged; Pefloxacin; Proteus Infections; Retrospective Studies; Sepsis; Time Factors

1990

[Combination of a 3d-generation cephalosporin (cefotaxime or ceftazidime) and a new quinolone (pefloxacine) in the treatment of febrile episodes in neutropenic diseases (37 cases)].

Presse medicale (Paris, France : 1983), 1987, Dec-16, Volume: 16, Issue:43

Topics: Agranulocytosis; Anti-Infective Agents; Cefotaxime; Ceftazidime; Drug Evaluation; Drug Therapy, Combination; Escherichia coli Infections; Feces; Fever; Focal Infection; Humans; Leukemia; Neutropenia; Norfloxacin; Pefloxacin; Pseudomonas Infections; Sepsis; Staphylococcal Infections

1987

Other Studies

11 other study(ies) available for pefloxacin and E coli Infections

Article	Year
Synthesis of novel 5-fluoro analogues of norfloxacin and ciprofloxacin. Journal of medicinal chemistry, 1989, Volume: 32, Issue:6 Topics: Animals; Chemical Phenomena; Chemistry; Ciprofloxacin; Enterobacter; Enterococcus faecalis; Escherichia coli; Escherichia coli Infections; Klebsiella pneumoniae; Magnetic Resonance Spectroscopy; Mice; Microbial Sensitivity Tests; Molecular Structure; Norfloxacin; Pseudomonas aeruginosa; Serratia marcescens; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship	1989
Studies on prodrugs. 7. Synthesis and antimicrobial activity of 3-formylquinolone derivatives. Journal of medicinal chemistry, 1988, Volume: 31, Issue:1 Topics: Animals; Anti-Bacterial Agents; Biological Availability; Ciprofloxacin; Escherichia coli Infections; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Indicators and Reagents; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Pharmaceutical Preparations; Prodrugs; Structure-Activity Relationship	1988
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:10 Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids	2008
Activity of combinations of ceftazidime, imipenem and pefloxacin against Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa. International journal of antimicrobial agents, 2003, Volume: 22, Issue:6 Topics: Animals; Ceftazidime; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Imipenem; In Vitro Techniques; Mice; Microbial Sensitivity Tests; Pefloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus	2003
Pefloxacin in rabbits: protein binding, extravascular diffusion, urinary excretion and bactericidal effect in experimental endocarditis. The Journal of antimicrobial chemotherapy, 1984, Volume: 14, Issue:1 Topics: Animals; Anti-Infective Agents; Diffusion; Endocarditis, Bacterial; Escherichia coli Infections; Furosemide; Male; Nalidixic Acid; Pefloxacin; Protein Binding; Rabbits	1984
Investigation of the potential role of Enterococcus faecalis in the pathophysiology of experimental peritonitis. The Journal of infectious diseases, 1994, Volume: 169, Issue:4 Topics: Abscess; Amoxicillin; Animals; Anti-Bacterial Agents; Bacteremia; Bacteroides fragilis; Bacteroides Infections; Body Weight; Disease Models, Animal; Drug Synergism; Enterococcus faecalis; Escherichia coli; Escherichia coli Infections; Gentamicins; Gram-Positive Bacterial Infections; Imipenem; Male; Microbial Sensitivity Tests; Ornidazole; Pefloxacin; Peritoneum; Peritonitis; Rats; Rats, Sprague-Dawley; Specific Pathogen-Free Organisms	1994
[Acute pyelonephritis in women. Short-term hospitalization]. Presse medicale (Paris, France : 1983), 1993, Nov-06, Volume: 22, Issue:34 Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Ampicillin Resistance; Drug Therapy, Combination; Escherichia coli Infections; Female; Humans; Length of Stay; Middle Aged; Netilmicin; Pefloxacin; Pyelonephritis; Urography	1993
Clinical experience with pefloxacin in patients with urinary tract infections. The British journal of clinical practice, 1990, Volume: 44, Issue:12 Topics: Adolescent; Adult; Aged; Bacterial Infections; Drug Resistance, Microbial; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Pefloxacin; Urinary Tract Infections	1990
Combination therapy: a way to limit emergence of resistance? The American journal of medicine, 1986, Jun-30, Volume: 80, Issue:6B Topics: Amikacin; Animals; Anti-Bacterial Agents; Ceftriaxone; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacter; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred ICR; Norfloxacin; Pefloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Serratia marcescens; Staphylococcal Infections; Staphylococcus aureus; Time Factors	1986
Evaluation of pefloxacin in experimental Escherichia coli meningitis. Antimicrobial agents and chemotherapy, 1986, Volume: 29, Issue:3 Topics: Animals; Anti-Infective Agents; Cefotaxime; Chloramphenicol; Escherichia coli Infections; Humans; Meningitis; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Rabbits; Time Factors	1986
Effects of sublethal concentrations of pefloxacin and ofloxacin on the adherence of Escherichia coli strains to human uroepithelial cells in vitro. Journal of chemotherapy (Florence, Italy), 1989, Volume: 1, Issue:4 Suppl Topics: Anti-Bacterial Agents; Bacterial Adhesion; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Humans; In Vitro Techniques; Pefloxacin; Urinary Tract Infections; Urothelium	1989